(Q39585273)

13 September 2017

title

Comparison of IFN-gamma responses to mycobacterial antigens as markers of response to BCG vaccination (English)

1 reference

13 September 2017

8

1 reference

13 September 2017

11

1 reference

13 September 2017

10

Gillian Black

1 reference

13 September 2017

Rosemary E Weir

1

1 reference

13 September 2017

Paul E M Fine

2

1 reference

13 September 2017

Sian Floyd

3

1 reference

13 September 2017

Sally Stenson

4

1 reference

13 September 2017

Carolynne Stanley

5

1 reference

13 September 2017

Keith Branson

6

1 reference

13 September 2017

Warwick J Britton

7

1 reference

13 September 2017

Mahavir Singh

9

1 reference

13 September 2017

publication date

1 January 2008

1 reference

13 September 2017

1 reference

13 September 2017

volume

88

1 reference

13 September 2017

issue

1

1 reference

13 September 2017

page(s)

31-38

1 reference

Real world TB vaccines: clinical trials in TB-endemic regions

13 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2007.10.001

BCG-induced increase in interferon-gamma response to mycobacterial antigens and efficacy of BCG vaccination in Malawi and the UK: two randomised controlled studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2007.10.001

T cell response to Mycobacterium tuberculosis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2007.10.001

Host responses and antigens involved in protective immunity to Mycobacterium tuberculosis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2007.10.001

Preclinical testing of new vaccines for tuberculosis: a comprehensive review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2007.10.001

Characterization of the secreted MPT53 antigen of Mycobacterium tuberculosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2007.10.001

Recombinant modified vaccinia virus Ankara expressing antigen 85A boosts BCG-primed and naturally acquired antimycobacterial immunity in humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2007.10.001

Protective effect of a tuberculosis subunit vaccine based on a fusion of antigen 85B and ESAT-6 in the aerosol guinea pig model

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2007.10.001

Comparison of T-cell-based assay with tuberculin skin test for diagnosis of Mycobacterium tuberculosis infection in a school tuberculosis outbreak

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2007.10.001

Interferon-gamma and skin test responses of schoolchildren in southeast England to purified protein derivatives from Mycobacterium tuberculosis and other species of mycobacteria

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2007.10.001

Human T cell responses to the ESAT-6 antigen from Mycobacterium tuberculosis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2007.10.001

Gamma interferon responses induced by a panel of recombinant and purified mycobacterial antigens in healthy, non-mycobacterium bovis BCG-vaccinated Malawian young adults

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2007.10.001

Members of the 30- to 32-kilodalton mycolyl transferase family (Ag85) from culture filtrate of Mycobacterium avium subsp. paratuberculosis are immunodominant Th1-type antigens recognized early upon infection in mice and cattle

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2007.10.001

Immunological and functional characterization of Mycobacterium leprae protein antigens: an overview.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2007.10.001

A new vaccine against tuberculosis affords greater survival after challenge than the current vaccine in the guinea pig model of pulmonary tuberculosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2007.10.001

The influence of previous exposure to environmental mycobacteria on the interferon-gamma response to bacille Calmette-Guérin vaccination in southern England and northern Malawi.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2007.10.001

T-cell recognition of the HspX protein of Mycobacterium tuberculosis correlates with latent M. tuberculosis infection but not with M. bovis BCG vaccination

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2007.10.001

Lack of immune responses to Mycobacterium tuberculosis DosR regulon proteins following Mycobacterium bovis BCG vaccination

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2007.10.001

Heterogenous expression of the related MPB70 and MPB83 proteins distinguish various substrains of Mycobacterium bovis BCG and Mycobacterium tuberculosis H37Rv

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2007.10.001

Evidence for occurrence of the ESAT-6 protein in Mycobacterium tuberculosis and virulent Mycobacterium bovis and for its absence in Mycobacterium bovis BCG.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2007.10.001

7 January 2021

T-cell recognition of Mycobacterium tuberculosis culture filtrate fractions in tuberculosis patients and their household contacts

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2007.10.001

7 January 2021

Molecular and immunological analyses of the Mycobacterium avium homolog of the immunodominant Mycobacterium leprae 35-kilodalton protein

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2007.10.001

7 January 2021

Evaluation of the recombinant 38-kilodalton antigen of Mycobacterium tuberculosis as a potential immunodiagnostic reagent

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2007.10.001

7 January 2021

10.1016/J.TUBE.2007.10.001

Identifiers

DOI

1 reference

13 September 2017

1 reference